NextGen Healthcare Stock Forecast, Price & News

NextGen Healthcare (NASDAQ:NXGN) Frequently Asked Questions

Is NextGen Healthcare a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last twelve months. There are currently 2 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NextGen Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NXGN, but not buy additional shares or sell existing shares.
View analyst ratings for NextGen Healthcare or view top-rated stocks.

What stocks does MarketBeat like better than NextGen Healthcare?

Wall Street analysts have given NextGen Healthcare a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but NextGen Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is NextGen Healthcare's next earnings date?

NextGen Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.
View our earnings forecast for NextGen Healthcare.

How were NextGen Healthcare's earnings last quarter?

NextGen Healthcare, Inc. (NASDAQ:NXGN) announced its earnings results on Thursday, July, 29th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.14 by $0.11. The company had revenue of $146.08 million for the quarter, compared to the consensus estimate of $139.97 million. NextGen Healthcare had a net margin of 2.31% and a trailing twelve-month return on equity of 12.73%.
View NextGen Healthcare's earnings history.

How has NextGen Healthcare's stock been impacted by Coronavirus (COVID-19)?

NextGen Healthcare's stock was trading at $11.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NXGN shares have increased by 32.0% and is now trading at $14.53.
View which stocks have been most impacted by COVID-19.

What guidance has NextGen Healthcare issued on next quarter's earnings?

NextGen Healthcare issued an update on its FY 2022 earnings guidance on Thursday, August, 5th. The company provided earnings per share guidance of $0.890-$0.950 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.910. The company issued revenue guidance of $576 million-$586 million, compared to the consensus revenue estimate of $579.64 million.

What price target have analysts set for NXGN?

8 equities research analysts have issued 1-year price targets for NextGen Healthcare's stock. Their forecasts range from $18.00 to $23.00. On average, they expect NextGen Healthcare's stock price to reach $20.71 in the next twelve months. This suggests a possible upside of 42.6% from the stock's current price.
View analysts' price targets for NextGen Healthcare or view top-rated stocks among Wall Street analysts.

Who are NextGen Healthcare's key executives?

NextGen Healthcare's management team includes the following people:

• L. Allen Plunk, Executive Vice President-Operations
• James R. Arnold, Chief Financial Officer & Executive Vice President
• David A. Metcalfe, Chief Technology Officer & Executive VP
• Betty Rabinowitz, Chief Medical Officer
• John S. Beck, Chief Solutions Officer & Executive Vice President

What is Rusty Frantz's approval rating as NextGen Healthcare's CEO?

248 employees have rated NextGen Healthcare CEO Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among NextGen Healthcare's employees.

Who are some of NextGen Healthcare's key competitors?

Some companies that are related to NextGen Healthcare include Parsons (PSN), Verint Systems (VRNT), Sykes Enterprises (SYKE), NetScout Systems (NTCT), Telos (TLS), Allscripts Healthcare Solutions (MDRX), Unisys (UIS), Agilysys (AGYS), Reinvent Technology Partners Y (RTPY), Ribbon Communications (RBBN), Ebix (EBIX), Simulations Plus (SLP), OneSpan (OSPN), Digimarc (DMRC) and Northern Genesis Acquisition Corp. II (NGAB).
View all of NXGN's competitors.

What other stocks do shareholders of NextGen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

What is NextGen Healthcare's stock symbol?

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

Who are NextGen Healthcare's major shareholders?

NextGen Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.87%), Brown Capital Management LLC (11.51%), Vanguard Group Inc. (8.89%), Dimensional Fund Advisors LP (3.61%), State Street Corp (2.73%) and Kennedy Capital Management Inc. (2.20%). Company insiders that own NextGen Healthcare stock include Craig A Barbarosh, David Ahmadzai, George H Bristol, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, John R Frantz, Lance Rosenzweig, Mitchell Waters and Sean Brynjelsen.
View institutional ownership trends for NextGen Healthcare.

Which institutional investors are selling NextGen Healthcare stock?

NXGN stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Brown Capital Management LLC, Russell Investments Group Ltd., First Trust Advisors LP, BlackRock Inc., Smith Graham & Co. Investment Advisors LP, AXA S.A., and Bank of America Corp DE. Company insiders that have sold NextGen Healthcare company stock in the last year include Craig A Barbarosh, David Ahmadzai, George H Bristol, John R Frantz, Lance Rosenzweig, and Mitchell Waters.
View insider buying and selling activity for NextGen Healthcare or view top insider-selling stocks.

Which institutional investors are buying NextGen Healthcare stock?

NXGN stock was acquired by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, JPMorgan Chase & Co., Millennium Management LLC, Point72 Asset Management L.P., Wade G W & Inc., Renaissance Technologies LLC, Bridgewater Associates LP, and Charles Schwab Investment Management Inc.. Company insiders that have bought NextGen Healthcare stock in the last two years include James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, and Sean Brynjelsen.
View insider buying and selling activity for NextGen Healthcare or or view top insider-buying stocks.

How do I buy shares of NextGen Healthcare?

Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NextGen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $14.53.

How much money does NextGen Healthcare make?

NextGen Healthcare has a market capitalization of $978.33 million and generates $556.82 million in revenue each year. The company earns $9.52 million in net income (profit) each year or $0.72 on an earnings per share basis.

How many employees does NextGen Healthcare have?

NextGen Healthcare employs 2,564 workers across the globe.

What is NextGen Healthcare's official website?

The official website for NextGen Healthcare is www.nextgen.com.

Where are NextGen Healthcare's headquarters?

NextGen Healthcare is headquartered at 18111 Von Karman Avenue Suite 800, Irvine CA, 92612.

How can I contact NextGen Healthcare?

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company can be reached via phone at (404) 467-1500 or via email at [email protected].